G1 Therapeutics Inc (STU:G1H)
€ 6.39 0 (0%) Market Cap: 339.15 Mil Enterprise Value: 327.68 Mil PE Ratio: 0 PB Ratio: 15.31 GF Score: 32/100

Q2 2022 G1 Therapeutics Inc Earnings Call Transcript

Aug 03, 2022 / 12:30PM GMT
Release Date Price: €8.34 (+4.38%)
Operator

Good day, and thank you for standing by. Welcome to the G1 Therapeutics Second Quarter 2020 Financial Results Call. (Operator Instructions). Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker for today, Mr. William Roberts. Please go ahead.

William C. Roberts
G1 Therapeutics, Inc. - VP of IR & Corporate Communications

Thank you, Mike. Good morning, everyone, and welcome to the G1 conference call to discuss our second quarter '22 financial results and business update. The press release on these financial results was issued this morning and can be found in the news section of our corporate website, g1therapeutics.com.

On this morning's call, the team will provide a business overview of the second quarter of '22, including an update on our clinical programs and our commercial progress in that period with COSELA, which is approved and commercially available to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot